Video

Dr. Dixon on Advances in Axillary Node Procedures

Dr. J. Michael Dixon from the University of Edinburgh on Advances in Breast Cancer Axillary Node Procedures

J. Michael Dixon, MBChB, MD, Professor of Surgery and Consultant Surgeon of the University of Edinburgh; and Clinical Director of the Edinburgh Breast Unit at the Western General Hospital in Edinburgh, Scotland, discusses how a shift in axillary lymph node procedures has positively affected breast cancer patients.

Since the advent of the sentinel node biopsy there has been a dramatic movement away from routinely removing axillary nodes. Focusing primarily on the sentinel nodes as the only axillary node procedure has increased recovery time and reduced the risk of lymphedema for breast cancer patients.

It is becoming even more clear that node dissection is often not necessary after completing a sentinel node biopsy, even if some of the nodes are positive.

Related Videos
Funda Meric-Bernstam, MD
Bhavana Pothuri, MD
Kristen Spencer, DO
Laurence Albigès, MD, PhD
Nirav Shah, MD, MSHP, discusses evaluating zamtocabtagene autoleucel in patients with relapsed/refractory diffuse large B-cell lymphoma.
Bhagirathbhai Dholaria, MBBS
Sairah Ahmed, M.D
Joshua K. Sabari, MD
Barry W. Goy, MD
Fred Saad, CQ, MD, FRCS, FCAHS, director, Prostate Cancer Research, Montreal Cancer Institute, Centre Hospitalier de l’Université de Montréal; full professor, Department of Surgery, Université de Montréal; uro-oncologist, Urology Department, University of Montreal Health Center